Stonnington Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $895K | Buy |
9,100
+1,500
| +20% | +$148K | 0.23% | 98 |
|
|
2022
Q4 | $847K | Sell |
7,600
-300
| -4% | -$33.4K | 0.23% | 98 |
|
|
2022
Q3 | $698K | Buy |
7,900
+3,700
| +88% | +$327K | 0.2% | 106 |
|
|
2022
Q2 | $371K | Buy |
4,200
+1,200
| +40% | +$106K | 0.1% | 166 |
|
|
2022
Q1 | $250K | Buy |
+3,000
| New | +$250K | 0.06% | 210 |
|
|
2021
Q4 | – | Sell |
-5,800
| Closed | -$451K | – | 247 |
|
|
2021
Q3 | $451K | Buy |
+5,800
| New | +$451K | 0.1% | 175 |
|